Sagimet Biosciences Inc (SGMT)
4.805
+0.06
(+1.37%)
USD |
NASDAQ |
May 21, 16:00
4.70
-0.10
(-2.19%)
After-Hours: 20:00
Sagimet Biosciences Total Assets (Quarterly): 194.53M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 194.53M |
December 31, 2023 | 96.72M |
September 30, 2023 | 102.92M |
June 30, 2023 | 21.50M |
Date | Value |
---|---|
March 31, 2023 | 27.25M |
December 31, 2022 | 33.03M |
March 31, 2021 | 77.20M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
21.50M
Minimum
Jun 2023
194.53M
Maximum
Mar 2024
79.02M
Average
77.20M
Median
Mar 2021
Total Assets (Quarterly) Benchmarks
Madrigal Pharmaceuticals Inc | 1.082B |
Viking Therapeutics Inc | 967.52M |
89bio Inc | 577.32M |
Arrowhead Pharmaceuticals Inc | 955.15M |
Akero Therapeutics Inc | 912.24M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 4.51M |
Shareholders Equity (Quarterly) | 190.02M |